POLYG

Polygiene

Market Cap 260.6M

Polygiene’s brand is based on its Polygiene Odor Control Technology, with a strategy built on ingredient branding similar to that of Gore-Tex or Windstopper. The company is currently the leading ingredient brand in the sport and outdoor segment, and focuses on premium brands for all kinds of clothing (sports, leisure, fashion, work), footwear and home textiles. Its customers (often called partners by the company) include Adidas, Patagonia, Athleta and Hugo Boss. The list of partners has increased from around 25 (2009) to more than 100 (2016). The additive itself is based on silver salt (silver chloride) made from recycled silver, and is currently used for textiles, foam, plastic or paint. In addition to its additive and ingredient branding, the company uses a comprehensive solution in order to work with the entire value chain and strengthen its competitiveness. These activities include application training for customers’ textile factories, brand training for customers' employees, consumer surveys, responsibility for customer support and complaints related to the Polygiene brand, and labels. The company employs 20 people and is headquartered in Malmo. In addition, the company has agents and distributors in over 20 locations worldwide and an advisory board. In 2016 sales were SEK 61 million and EBIT SEK -2 million. Polygiene has been traded on First North Stockholm since March 2016.

+ more
0.00
Today
Day High
12.70
12.7
Day Low
12.70
Day Open
12.85
Prev Close
12.70
VWAP
12.7
Volume
1K
Turnover
0.015M
Top Broker
ENS
VWAP
12.8
Avg Volume
12K
Avg Turnover
0.153M
Top Brokers
AVA/MLI
VWAP
12.5
Avg Volume
17K
Avg Turnover
0.209M
Top Brokers
AVA/UBS
VWAP
12.6
Avg Volume
23K
Avg Turnover
0.295M
Top Brokers
AVA/NON
52 week summary
Price Range
10.3
Last
14.0
Beta
N/A
Market Cap
260.6M
Total Return
6.7%
Trailing P/E
-115.6
Div Yield
0.0%
Shares Outstanding
20.5M
Stock Exchange
First North Stockholm
5 day chart Go to advanced chart

Identify and measure trend strength in stocks with our Momentum tool to identify potential entry and exit signals. The tool provides a set of the most simple but powerful indicators that identify whether a stock is under sell or buy pressure.

Relative Price Strength
Change 3 Months 10.4%
Change 12 Months 8.1%
Volume Trend
Average Volume 10 vs 60 Days -21.7%
Price VS
52 Week High -9.3%
50 Day Moving Average 5.3%
200 Day moving Average 10.1%

Add article markers

Compare Polygiene to

Prev Close 0 Change 0
High 0 Avg Daily Volume 0
Low 0 Avg Daily Turnover 0
  • Management
  • Ulrika Björk, CEO
  • Ulrika Björk, CFO
  • Peter Sjösten, CCO
  • Executive board
  • Richard Tooby, Chairman of the board
  • Jonas Wollin
  • Mats Georgson
  • Jonas Sjögren
  • Daniel Oelker
  • Lennart Holm
Last updated: 2018-01-09 Source: Redeye
Major Owners Equity Votes
Richard Tooby 10.1%
10.1%
JP Morgan Bank Luxembourg 9.4%
9.4%
Erik A i Malmö AB 6.6%
6.6%
Clearstream Banking S.A. Luxembourg 6.2%
6.2%
JPM Chase NA 4.6%
4.6%
Christian von Uthmann 4.4%
4.4%
Jonas Wollin 4.0%
4.0%
Lennart Holm 3.9%
3.9%
Aktia Fund Management 3.9%
3.9%
Mats Georgson 3.4%
3.4%
Last updated: 2017-11-13 Source: Redeye
Timeframe Transactions Net Shares
Last 12 weeks
0 Purchases
0
1 Sales
-100,000
Last 24 weeks
0 Purchases
0
1 Sales
-100,000
Report Date Name Position Transaction Shares Chg Est Value (SEK)

Catalyst Potential is behind membership

To access members-only content, you must login or register an account.

Our membership is about gaining access to unique research and knowledge through our analysts and a network of peers. Be the first to get information about news and research in the Nordic life science and technology sectors and use our tools and education to reach your personal and professional goals in investing.

Source: Millistream
  •  
  • Profitability
  • ROE
  • ROCE
  • ROIC
  • EBITDA margin
  • EBIT margin
  • Net margin
  • Per share data (SEK)
  • EPS
  • EPS adj
  • Dividend
  • Net debt
  • Total shares
  • Valuation
  • EV (SEKm)
  • P/E
  • P/E diluted
  • P/Sales
  • EV/Sales
  • EV/EBITDA
  • EV/EBIT
  • P/BV
  • Capital structure
  • Equity ratio
  • Debt/equity ratio
  • Net debt(SEKm)
  • Capital employed(SEKm)
  • Capital turnover rate
  • (SEKm)
  • Net sales
  • Total operating costs
  • EBITDA
  • Depreciation
  • Amortization
  • Impairment charges
  • EBIT
  • Share in profits
  • Net financial items
  • Exchange rate dif.
  • Pre-tax profit
  • Tax
  • Net earnings
  • (SEKm)
  • Assets
  • Current assets
  • Cash in banks
  • Receivables
  • Inventories
  • Other current assets
  • Current assets
  • Fixed assets
  • Tangible assets
  • Associated comp.
  • Investments
  • Goodwill
  • Cap. exp. for dev.
  • O intangible rights
  • O non-current assets
  • Total fixed assets
  • Deferred tax assets
  • Total (assets)
  • Liabilities
  • Current liabilities
  • Short-term debt
  • Accounts payable
  • O current liabilities
  • Current liabilities
  • Long-term debt
  • O long-term liabilities
  • Convertibles
  • Total Liabilities
  • Deferred tax liab
  • Provisions
  • Shareholders' equity
  • Minority interest (BS)
  • Minority & equity
  • Total liab & SE
  • (SEKm)
  • Net sales
  • Total operating costs
  • Depreciations total
  • EBIT
  • Taxes on EBIT
  • NOPLAT
  • Depreciation
  • Gross cash flow
  • Change in WC
  • Gross CAPEX
  • Free cash flow
  • 2014
  •  
  • 0.0%
  • 0.0%
  • 0.0%
  • 10.6%
  • 10.6%
  • 15.5%
  •  
  • 0.00
  • 0.00
  • 0.00
  •  
  • 0.0
  •  
  • 0.0
  • 0.0
  • 0.0
  • 0.0
  • 0.0
  • 0.0
  • 0.0
  • 0.0
  •  
  • 0.0%
  • 0.0%
  • 0
  • 0
  • 0.0
  • 2014
  •  
  •  
  • 0
  • 0
  • 0
  • 0
  • 0
  •  
  • 0
  • 0
  • 0
  • 0
  • 0
  • 0
  • 0
  • 0
  • 0
  • 0
  •  
  •  
  • 0
  • 0
  • 0
  • 0
  • 0
  • 0
  • 0
  • 0
  • 0
  • 0
  • 0
  • 0
  • 0
  • 0
  • 2014
  • 35
  • -31
  • 0
  • 4
  • -1
  • 3
  • 0
  • 3
  • 0
  • 0
  • 5
  • 2014 Q4
  • 35
  • -31
  • 4
  • 0
  • 0
  • 0
  • 4
  • 0
  • 0
  • 0
  • 4
  • 2
  • 5
  • 2015
  •  
  • 0.0%
  • 27.4%
  • 0.0%
  • 10.9%
  • 10.9%
  • 17.7%
  •  
  • 0.47
  • 0.47
  • 0.00
  •  
  • 19.3
  •  
  • -27.5
  • 0.0
  • 0.0
  • 0.0
  • -0.5
  • -4.9
  • -4.9
  • 0.0
  •  
  • 81.0%
  • 0.0%
  • -28
  • 13
  • 1.0
  • 2015
  •  
  •  
  • 28
  • 14
  • 0
  • 3
  • 45
  •  
  • 0
  • 0
  • 0
  • 0
  • 0
  • 0
  • 0
  • 0
  • 5
  • 50
  •  
  •  
  • 0
  • 10
  • 0
  • 10
  • 0
  • 0
  • 0
  • 10
  • 0
  • 0
  • 41
  • 0
  • 41
  • 50
  • 2015
  • 52
  • -46
  • 0
  • 6
  • -1
  • 4
  • 0
  • 4
  • -8
  • 0
  • -4
  • 2015 Q1
  • 7
  • -7
  • 0
  • 0
  • 0
  • 0
  • 0
  • 0
  • 0
  • 0
  • 0
  • 0
  • 0
  • 2015 Q2
  • 11
  • -10
  • 1
  • 0
  • 0
  • 0
  • 1
  • 0
  • 0
  • 0
  • 1
  • 0
  • 1
  • 2015 Q3
  • 19
  • -16
  • 3
  • 0
  • 0
  • 0
  • 3
  • 0
  • 0
  • 0
  • 3
  • 0
  • 3
  • 2015 Q4
  • 15
  • -13
  • 2
  • 0
  • 0
  • 0
  • 2
  • 0
  • 0
  • 0
  • 2
  • 4
  • 5
  • 2016
  •  
  • -5.2%
  • -5.7%
  • -15.9%
  • -3.8%
  • -3.8%
  • -3.5%
  •  
  • -0.11
  • -0.11
  • 0.00
  •  
  • 19.6
  •  
  • 214.2
  • -110.5
  • -110.5
  • 3.8
  • 3.5
  • -91.0
  • -91.0
  • 5.7
  •  
  • 72.0%
  • 0.0%
  • -20
  • 21
  • 1.1
  • 2016
  •  
  •  
  • 20
  • 30
  • 0
  • 2
  • 52
  •  
  • 0
  • 0
  • 0
  • 0
  • 0
  • 0
  • 0
  • 0
  • 6
  • 57
  •  
  •  
  • 0
  • 16
  • 0
  • 16
  • 0
  • 0
  • 0
  • 16
  • 0
  • 0
  • 41
  • 0
  • 41
  • 57
  • 2016
  • 61
  • -64
  • 0
  • -2
  • 0
  • -2
  • 0
  • -2
  • -8
  • 0
  • -11
  • 2016 Q1
  • 13
  • -14
  • 0
  • 0
  • 0
  • 0
  • 0
  • 0
  • 0
  • 0
  • 0
  • 0
  • 0
  • 2016 Q2
  • 13
  • -15
  • -2
  • 0
  • 0
  • 0
  • -2
  • 0
  • 0
  • 0
  • -2
  • 0
  • -2
  • 2016 Q3
  • 15
  • -15
  • 0
  • 0
  • 0
  • 0
  • 0
  • 0
  • 0
  • 0
  • 0
  • 0
  • 0
  • 2016 Q4
  • 20
  • -20
  • 1
  • 0
  • 0
  • 0
  • 1
  • 0
  • 0
  • 0
  • 1
  • 0
  • 1
  • 2017 E
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  • 2017 E
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  • 2017 E
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  • 2017 Q1 E
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  • 2017 Q2 E
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  • 2017 Q3 E
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  • 2017 Q4 E
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  • 2018 E
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  • 2018 E
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  • 2018 E
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  • 2018 Q1 E
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  • 2018 Q2 E
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  • 2018 Q3 E
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  • 2018 Q4 E
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  • 2019 E
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  • 2019 E
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  • 2019 E
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  • 2019 Q1 E
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  • 2019 Q2 E
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  • 2019 Q3 E
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  • 2019 Q4 E
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  

Estimated Values is behind membership

To access members-only content, you must login or register an account.

Our membership is about gaining access to unique research and knowledge through our analysts and a network of peers. Be the first to get information about news and research in the Nordic life science and technology sectors and use our tools and education to reach your personal and professional goals in investing.

Last updated: 2017-11-13 Source: Redeye
Source: Redeye

Presentations, research interviews and videos from our events listed here.

Source: Redeye

Community Posts

Be the first to write something about this company in the community.

Create new post